Art Unit 2122
Group 2120Artificial Intelligence
- Active examiners
- 42
- Average office actions per grant
- 2.13
Grant ratio
- Art Unit 2122
- 57.6%
- Group 2120
- 63.6%
Active examiners
| Wilbert L Starks | 65.6% | 1.69 | August 2026 |
|---|---|---|---|
| Ababacar Seck | 65.2% | 2.12 | June 2026 |
| Eric Nilsson | 79.1% | 1.95 | August 2026 |
| Brian M Smith | 37.2% | 2.83 | August 2026 |
| Luis Sitiriche | 80.0% | 2.13 | August 2026 |
| Daniel Pellett | 70.6% | 2.35 | August 2026 |
| Kevin L. Smith | 23.2% | 3.50 | August 2026 |
| Michael H Hoang | 22.7% | 2.83 | August 2026 |
| Ben Rifkin | 42.7% | 3.06 | August 2026 |
| Brandon S. Cole | 85.5% | 1.91 | August 2026 |
| Johnathan R Germick | 27.5% | 2.81 | August 2026 |
| Vincent Gonzales | 68.3% | 2.04 | August 2026 |
| Dave Misir | 83.8% | 1.38 | August 2026 |
| Omar F. Fernandez Rivas | 85.1% | 1.64 | June 2026 |
| Su-Ting Chuang | 50.7% | 3.11 | August 2026 |
| Robert N Day | 3.0% | 2.50 | August 2026 |
| Josep Han | 0.0% | N/A | August 2026 |
| Viker A. Lamardo | 43.6% | 2.88 | June 2026 |
| Charles Jeffrey Jones Jr | 0.0% | N/A | August 2026 |
| Kevin W Figueroa | 63.0% | 2.94 | August 2026 |
| Molly Clarke Sippel | 0.0% | N/A | August 2026 |
| Shien Ming Chou | 58.7% | 3.22 | August 2026 |
| Kidest Bahta | 83.7% | 1.57 | August 2026 |
| Ibrahim Rahman | 0.0% | N/A | August 2026 |
| Jacob Z Sussman Moss | 0.0% | N/A | August 2026 |
| Crystal J. Barnes-Bullock | 82.4% | 1.64 | August 2026 |
| Nathan L Laughlin | 55.9% | 2.21 | August 2026 |
| Tyler E Iles | 0.0% | N/A | July 2026 |
| Brent Hoover | 70.8% | 1.98 | August 2026 |
| Carlos R Ortiz Rodriguez | 57.1% | 2.09 | August 2026 |
| Marshall Werner | 40.0% | 2.68 | August 2026 |
| Alexander J Kosowski | 63.2% | 2.10 | August 2026 |
| Kelvin Booker | 66.7% | 2.11 | August 2026 |
| Mai T Tran | 5.6% | 2.00 | July 2026 |
| Natnael A Asegdew | 0.0% | N/A | August 2026 |
| Adam Clark Standke | 71.4% | 3.32 | August 2026 |
| Liliana Cerullo | 0.0% | 1.00 | July 2026 |
| Asher H. Jablon | 33.3% | 3.22 | August 2026 |
| Vi N Tran | 66.7% | 3.69 | August 2026 |
| Chaitanya Ramesh Jayakumar | 50.0% | 2.75 | July 2026 |
| Prayukta Ghimire | 0.0% | N/A | August 2026 |
| Alvaro S Laham Bauzo | 0.0% | N/A | August 2026 |
Examiner distribution
- Median grant ratio
- 55.9%
- Middle 50% of grant ratios
- 22.9%–70.7%
- Median office actions / grant
- 2.21
- Middle 50% of office actions / grant
- 1.95–2.83
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Michael Zidanic | 60.7% | 2.25 | November 2019 Appears inactive |
|---|---|---|---|
| The Examiner Peter Coughlan | 75.6% | 2.36 | November 2023 Appears inactive |
| Walter Hanchak | 68.3% | 2.16 | December 2016 Appears inactive |
| Fuming Wu | 59.5% | 2.41 | June 2019 Appears inactive |
| Mai T. Tran | 79.2% | 1.71 | December 2017 Appears inactive |
| Kalpana Bharadwaj | 83.3% | 1.64 | February 2017 Appears inactive |
| Robert Lewis Kulp | 61.4% | 3.21 | December 2023 Appears inactive |
| Jesse Chen Coulson | 2.6% | 1.00 | April 2026 Potentially inactive |
| Michael D. Masinick | 73.5% | 1.80 | March 2023 Appears inactive |
| Tejal J. Gami | 43.8% | 2.43 | December 2023 Appears inactive |
| Ying Yu Chen | 50.0% | 2.35 | December 2023 Appears inactive |
| Nader S Metwalli | 82.8% | 1.71 | April 2020 Appears inactive |
| Vasyl Dykyy | 60.0% | 1.93 | March 2021 Appears inactive |
| Sivalingam Sivanesan | 75.0% | 1.73 | October 2018 Appears inactive |
| Mario Riojas | 87.5% | 1.36 | July 2013 Appears inactive |
| Charles C Kuo | 42.9% | 3.32 | May 2025 Appears inactive |
| Isidore Sobkowski | 71.4% | 1.40 | July 2015 Appears inactive |
| Sunhwa A Nam | 0.0% | N/A | May 2025 Appears inactive |
| Elliott Graham Miller | 25.0% | 1.00 | July 2024 Appears inactive |
| Peter J Walsh | 25.0% | 1.00 | September 2023 Appears inactive |
| Chioma Ugonabo | 66.7% | 1.50 | August 2024 Appears inactive |
| Benjamin H. Rieland | 100.0% | 1.00 | May 2023 Appears inactive |
| Peter Thompson | 100.0% | 1.00 | January 2011 Appears inactive |
Based on available public USPTO records; may be incomplete.